Search

everythinglearnresearchcommunity

for

Search:↓

FDG PET/CT scans can change cancer treatment plans for dogs.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Wnt7a protein is crucial for development and tissue maintenance and plays varying roles in diseases and potential treatments.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

AI is revolutionizing healthcare by improving diagnosis, treatment, and monitoring, but still needs close supervision.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

People with Birt-Hogg-Dubé syndrome often have lung problems and delayed diagnosis, and better recognition of CT scan signs could improve diagnosis and management.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Men who start losing hair at 20 may have a higher chance of getting prostate cancer later.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.